High-intensity exercise program for older adults with HIV to improve vascular and cognitive health
Official title: A Pilot Trial of High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Older Adults With HIV
Run by University of Alabama at Birmingham · NCT05965518 · Data updated 2026-11-12
This study tests whether a 16-week high-intensity exercise program can help older adults with HIV improve their heart and brain health compared to a moderate exercise routine.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | February 5, 2024 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT05965518 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 50 and older with HIV who are sedentary and experiencing cognitive impairments.
✕Probably not a fit
Patients with uncontrolled hypertension, severe cardiac disease, or other significant health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of a 16-week high-intensity interval training (HIIT) program on vascular and cognitive function in adults aged 50 and older living with HIV who have suboptimal cognition. Participants will be randomly assigned to either the HIIT group or a continuous moderate exercise group, with the aim of determining which approach yields greater improvements in health outcomes. The study will also explore barriers to exercise engagement and participants' perceptions of the interventions through qualitative interviews. Data will be collected at baseline and after the intervention to assess changes in vascular function and cognitive performance.
Why it matters
Potential benefit: If successful, this study could lead to improved vascular and cognitive health for older adults living with HIV.
How similar studies have gone: While there is ongoing research in exercise interventions for HIV patients, this specific approach using HIIT in older adults is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 50 years and older * Sedentary lifestyle, defined as \< 150 min/wk moderate physical activity as assessed by CHAMPS questionnaire * Neurocognitive Impairment (as assessed using the BRACE+ * Prescribed HIV ART for ≥ 12 months, with no current use of older drugs with established mitochondrial toxicity * Able to speak, read, and write in English * Willingness to participate in all study procedures Exclusion Criteria: * Diagnosis of mitochondrial disease * Active substance abuse or factors preventing compliance or safety * Uncontrolled hypertension, defined as resting BP \> 150/90 mmHG * Chronic kidney disease * Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina * Acute myocardial infarction identified by medical history and ECG * Pulmonary disease requiring the use of supplemental oxygen * Poorly controlled diabetes * Neuropsychologically Intact * Orthopedic problems that limit ability to perform exercise * Simultaneous participation in another intervention trial
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting
Study contacts
- Principal investigator: Raymond Jones, Ph.D. — University of Alabama at Birmingham
- Study coordinator: Raymond Jones, Ph.D.
- Email: raymondjones@uabmc.edu
- Phone: 205-996-3569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
Immersive nature-based wellbeing program for older adults with cognitive impairment
A nature-inspired immersive virtual reality program is being tested to see if it can improve well-being and daily function for older adults with mild to moderate cognitive impairment.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Sleep and arterial function in hypertensive patients with poor sleep quality
This trial tests whether using cognitive-behavioural therapy for insomnia can improve artery health and well-being in adults with high blood pressure and poor sleep.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.